Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG).
about
Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG).
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Efficacy and tolerability of r ...... ean Cancer Study Group (KCSG).
@en
Efficacy and tolerability of r ...... the Korean Cancer Study Group
@nl
type
label
Efficacy and tolerability of r ...... ean Cancer Study Group (KCSG).
@en
Efficacy and tolerability of r ...... the Korean Cancer Study Group
@nl
prefLabel
Efficacy and tolerability of r ...... ean Cancer Study Group (KCSG).
@en
Efficacy and tolerability of r ...... the Korean Cancer Study Group
@nl
P2093
P50
P1433
P1476
Efficacy and tolerability of r ...... rean Cancer Study Group (KCSG)
@en
P2093
Byoung Yong Shim
Chi Hoon Maeng
Dae Ro Choi
Dae Young Zang
Do Youn Oh
Eun Kee Song
Hong Suk Song
Hye Sook Han
Hyun Woo Lee
In Gyu Hwang
P2888
P304
P356
10.1007/S10120-018-0806-1
P577
2018-02-09T00:00:00Z